Active · since Jun 19, 2023 Branch
PFIZER BRASIL LTDA · branch in Guarulhos (SP)
CNPJ 61.072.393/0051-00
Source: Receita Federal, CNPJ Open Data · October 2026 publication
- Opened on
- 3 years ago
- Establishment
- 5 active
- of 50 registered
AGUA CHATA
GUARULHOS - SP
CEP 07251-500
Partners and contacts
The telephone and e-mail the Receita publishes for this establishment are shown here when you ask, and never to search engines. Without its own, we show the head office's. The partners are the company's, on a page of their own.
See the company's partnersSummary
This is the Guarulhos (SP) establishment of PFIZER BRASIL LTDA, opened on Jun 19, 2023. Its main activity is manufacture of allopathic medicines for human use (2121-1/01). It is one of the company's 5 active establishments.
What this establishment does
CNAE 2121-1/01 · mainManufacture of allopathic medicines for human use
The company's
What holds for every establishment
- Legal name
- PFIZER BRASIL LTDA
- Legal form
- 2062 — Limited liability company (Ltda.)
- Share capital
- R$ 1,506,484,132.00
- Size
- Other
- Partners
- See the company's partners
This establishment's registration
as the Receita Federal publishes it- CNPJ
- 61.072.393/0051-00
- Registration status
- Active, since Jun 19, 2023
- Opened on
- Jun 19, 2023
- Head office
- 61.072.393/0001-33
This establishment's history
since September 2023No change to this establishment since September 2023.
- September 2023Start of dembli's monthly history
The first Receita publication dembli keeps of this establishment.
Frequently asked questions
What is the CNPJ of PFIZER BRASIL LTDA's head office?
The head office is CNPJ 61.072.393/0001-33, in São Paulo (SP). Every establishment of the company shares the same first eight digits, 61.072.393.
Is branch 61.072.393/0051-00 active?
According to the Receita Federal's October 2026 publication, this establishment's registration status is active since Jun 19, 2023.
What does the Guarulhos (SP) branch do?
The main activity this establishment declares is manufacture of allopathic medicines for human use (2121-1/01).